RUNX-3-expressing CAR T cells targeting glypican-3 in patients with heavily pretreated advanced hepatocellular carcinoma: a phase I trial.
Fu Q, Zheng Y, Fang W, Zhao Q, Zhao P, Liu L, Zhai Y, Tong Z, Zhang H, Lin M, Zhu X, Wang H, Wang Y, Liu Z, Yuan D, Bao X, Gao W, Dai X, Li Z, Liang T.
Fu Q, et al. Among authors: zhao p, zhao q.
EClinicalMedicine. 2023 Aug 30;63:102175. doi: 10.1016/j.eclinm.2023.102175. eCollection 2023 Sep.
EClinicalMedicine. 2023.
PMID: 37680942
Free PMC article.